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Abstract
Cryptococcus neoformans is an opportunistic pathogen which attacks individuals with weakened immune systems. Two C. neo-
formans isolates, 184A and NU-2, were examined to determine characteristics that contribute to their difference in virulence.
Both isolates were grown under tissue culture conditions, and different characteristics were tested at timed intervals. Isolate
184A was found to grow at a faster rate than isolate NU-2, with doubling times of 4 and 12 hours respectively. The polysac-
charide capsule of isolate NU-2 doubled in size in four hours, while that of isolate 184A stayed approximately the same. The
NU-2 yeast cell diameter without the polysaccharide capsule was initially bigger than 184A at 3.62 pm and continued to
increase although the diameter of isolate 184A stayed approximately the same at 2.41 pm. Isolate NU-2 shed excessive cap-
sular material into the media, but isolate 184A shed little. These findings highlight some major differences in the characteris-
tics of the two isolates which may contribute to the differing degrees of virulence.
Introduction
Cryptococcus neoformans is a ubiquitous yeast-like organ-
ism which causes cryptococcosis. The occurrence of this dis-
ease has increased in recent years due to the increase in
immunocompromised individuals such as AIDS patients.
Humans are frequently exposed to C. neoformans, yet the
occurrence ofcryptococcosis in immunocompetent individ-
uals is relatively low.In contrast, individuals with depressed
cell-mediated immunity (CMI) function due to chemothera-
py, underlying malignancy, or infectious disease such as
AIDS are extremely susceptible to a C. neoformans infection(Murphy, 1989). The organism is acquired through inhala-
tion of the desiccated yeast cells in contaminated dust
(Kwon-Chung and Bennett, 1992) and may cause an asymp-
tomatic to mild pulmonary infection before it spreads to
extrapulmonary sites. C. neoformans has a predilection for
the central nervous system, and the majority ofcryptococcal
disease is diagnosed as meningitis or meningoencephalitis
(Murphy, 1989).
There are four serotypes of C. neoformans (A, B. C, D),
but virtually 100 percent of the AIDSpatients in the United
States with cryptococcosis are infected with serotype A
cryptococci (Cherniak and Sundstrom, 1994). Among the
many isolates of serotype A are cultures 184A and NU-2.
These two isolates are known to be quite different from one
another with respect to host clearance (Murphy unpub.
observ.). In an experiment designed to display this differ-
ence, each isolate was injected intratracheally into naive
mice. Sixty percent of the 184A infected mice survived to 95
days post-infection which was the end point of the
experiment, but 100% of the NU-2 infected mice died by the
67th day of infection (Murphy unpublished observ.). In this
situation, isolate NU-2 was clearly more virulent than isolate
184A.
This research focuses on determining the morphologi-
cal and growth differences between these two isolates of C.
neoformans. Knowing the combination of host and pathogen
factors which are associated with either mild or severe dis-
ease may allow for the development of procedures which
interfere with the virulence factors of the pathogen therebye
reducing the incidence or extent of the disease in immuno-
compromised patients.
The first characteristic of the isolates examined was rate
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ofgrowth. One possible reason for the increased level of vir-
ulence observed in mice of isolate NU-2 over 184A may be
due to faster rates of growth and reproduction. To test this
possiblity, the growth rate of each isolate was determined
under tissue culture conditions.
A second characteristic of the isolates that was exam-
ined was the diameter of the yeast cell without the polysac-
charide capsule. The cell diameter with and without the
polysaccharide capsule was measured, and the data from the
two parameters was used to characterize the yeast cells.
A third characteristic that was examined was the kinet-
ics of polysaccharide capsule formation. The presence of a
polysaccharide capsule is known to contribute to the viru-
lence of C. neoformans (Bulmer et al.,1967; Fromtling et al.,
1982; Kozel and Cazin, 1971; Kwon-Chung and Rhodes,
1986). Both isolates have a polysaccharide capsule, but as
time progresses in tissue culture medium, isolate NU-2 is
able to increase capsule synthesis (Cherniak and Sundstrom,
1994). Using differential display PCR, differentially
expressed genes for capsule production or other possible
virulence factors can be examined. For this procedure, how-
ever, mRNA must be isolated, and the excessive capsule
production of NU-2 can interfere with RNA isolation. By
examining the kinetics of capsule production, the optimal
time for RNA isolation— when the transcripts involved in
capsule production are abundant, but little capsular materi-
al is produced— can be found. This willpermit the study of
the capsular genes which willbe helpful in identifying viru-
lence mechanisms. This in turn may allow for the augmen-
tation of host resistance or therapeutic inhibition of the vir-
ulence factors.
The polysaccharide capsule production was also tested
with a latex agglutination test. This test measures the
amount of capsular material the isolate has shed into the cul-
ture medium. This will help determine when the isolates
begin capsular production and the peak of that production.
This along with the other data yields the optimal time for
mRNA retrieval.
Allof these factors may combine to make isolate NU-2
more virulent. The information obtained from these experi-
ments may provide further insight into the causes of this vir-
ulence which could lead to more effective control of crypto-
coccosis.
Materials and Methods
Cryptococcus neoformans isolate 184 A was isolated from
he sputum of a patient at Charity Hospital inNew Orleans,
Louisiana in 1958. C. neoformans isolate NU-2 was isolated at
he University of Nebraska School of Medicine, Department
of Microbiology. Both isolates are serotype A with similar
glucuronoxylomannan (GXM) structure and are alpha mat-
ing type.
Isolates were initially grown on Modified Sabourauds
Agar (MSA) slants. For each experiment and isolate, three-
day cultures were transferred to fresh slants and two days
later used for the experiments. Isolates were washed off the
MSA slants with sterile physiological saline solution (SPSS).
Organisms were washed 3 times in SPSS and resuspended
in RPMI, pH 6.8. They were then counted on a hemacy-
tometer and resuspended at a concentration of 104 organ-
isms/ml. One mlof the organisms inRPMI solution pH 6.8
was then added to each of three 14 ml tubes per isolate per
time point. The inoculation of the tubes was done under the
hood, and the tubes were incubated at 37°C, in a 7%
atmosphere of CO2.
The growth curve was determined by hemacytometer
counts at 0, 4, 8, 12, 24, and 48 hours after inoculation. The
number of C. neoformans cells/ml from the three tubes was
averaged to obtain the mean for each time point.
The time points for the measurement of the diameter of
the yeast cells without the polysaccharide capsules and the
diameter of the polysaccharide capsules themselves were 0,
4, 8, 12, 24 ,and 48 hours. At each time point the yeast cells
in the inoculated tubes used for the hemacytometer count
were measured. After the yeast cells were removed for the
hemacytometer count, the rest of the solution was trans-
ferred to three 1.6 ml centrifuge tubes per isolate. The three
tubes were centrifuged for 10 minutes at 600 g. Two-hun-
dred ul of the supernatant fluid was removed from each of
the tubes and pooled into a 1.6 ml tube and frozen at -20°C.
Ten ul of remaining solution was put on a microscope slide
with 37 ul of India Ink. A coverslip was then added. The
diameters of the yeast cells both with and without the cap-
sules were measured with an ocular micrometer. The diam-
eters of the capsules were obtained by subtracting the diam-
eters of the yeast cells without the capsules from the diame-
ters of the yeast cells with the capsules. Approximately 100
cells/isolate were measured for each time point. These num-
bers were averaged to get a mean value for both measure-
ments.
The Latex-Crypto Antigen Detection System (Immuno-
Mycologics, Inc.,Norman, OK) was used for the latex agglu-
tination test or the soluble polysaccharide determination.
Frozen supernatant was thawed for approximately 15 min-
utes; then 25 ul was added to the ring slide provided by the
kit along with 25 jul of the Anti-Cryptococcus Globulin
Reagent (ACGR). They were mixed and shaken at 100 rpm
for 10 minutes. The reaction was then read according to the
manufacturer's instructions. If the reaction was positive, 50
ulof the supernatant was added to 50 ul of a 1:10 dilution of
the diluent with deionized water creating a 1:2 titer.Twenty-
five ulof the 1:2 titerand 25 |ilof the ACGR were added to
a ring slide, mixed, and shaken for 10 minutes at 100 rpm.
The reaction was then read. The dilution was increased log-
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arithmically until a negative reaction occurred.
Means, standard errors of the means (SEM) and
Student's t test were used for statistical analysis of the data.
Results were considered significant ifthe P value was <0.05.
Results
The first objective of the experiment was to construct a
growth curve for each isolate of C. neoformans. Separate cul-
tures of each isolate were initiated with equivalent numbers
of cells/ml. The hemacytometer count values were used to
construct the growth curves. The mean values for cells/ml at
each time point are shown in Fig. 1. The data from this
experiment show that the doubling time for isolate 184A
was approximately 4 hours while the doubling time of iso-
late NU-2 was approximately 12 hours. The data shown are
representative of three experiments. These data demon-
strates that isolate 184A reproduces more rapidly inculture
than isolate NU-2.
Time (hours)
Fig. 1. Growth rate of C. neoformans isolates 184A or NU-2
in RPMI at 37°C in the presence of 7% CO2.Error bars
represent mean ± standard error of the mean of three deter-
minations.
The diameter of the yeast cells without the polysaccha-
ride capsule was another aspect of the two isolates that was
measured. This measurement helped make the polysaccha-
ride capsule measurements more significant because it
showed a trend in the size of the inner part of the cells with-
out the capsule. The mean values of the diameters of the
inner part of the cells of the isolates at the successive time
Fig. 2. Yeast cell diameter without the polysaccharide cap-
sule for C. neoformans isolates 184A and NU-2. Error bars
represent mean ± standard error of the mean of 100 deter-
minants.
Time (hours)
Fig. 3. Polysaccharide capsule diameter of C. neoformans iso-
lates 184A or NU-2. Error bars represent mean ± standard
error of the mean of 100 determinations.
points are shown in Fig. 2. The cells of isolate NU-2 pos-
sessed diameters that were larger at time zero than isolate
184A and continued to increase in size whereas the diame-
ters of the yeast cells of isolate 184A stayed relatively con-
stant throughout the course of the experiment. These data
represent two experiments.
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Table 1. Latex agglutination results for C. neoformans isolates 184A or NU-2 at various time points.
Hours Isolate 184A Isolate NU-2
0 = + UNDILUTED
4 I +(1:4)
8 +(1:32)
J2 + UNDILUTED +(1:128)
24 +(l:64)a +(1:512)
48 + (1:256) + (1:2048)
a Values are the titer from latex agglutination kit.
Next, we observed the kinetics of the polysaccharide
capsular production. The mean values of the diameter of the
polysaccharide capsule over 48 hours are shown in Fig. 3.
By eight hours the average diameter of the yeast cells' cap-
sules of isolate NU-2 had doubled while the mean diameter
of capsules for isolate 184A had decreased slightly. Yeast
cells ofisolate NU-2 possessed capsule diameters that stayed
roughly the same from 8 to 48 hours. The diameter of yeast
cell capsules of isolate 184A did not change significantly
during culture. These data represent twoexperiments.
Both isolates are known to have a polysaccharide cap-
sule, but it is not clear at what point the capsule production
peaks. A specific latex agglutination test was used to deter-
mine the amount of polysaccharide capsular material shed
into the medium. Isolate 184 Adid not show a positive reac-
tion until 12 hours (Table 1), but its titers did begin to
increase at subsequent hours. Isolate NU-2 showed a posi-
tive reaction at zero hours which means that itprobably was
not washed well enough, but it continued to increase its
titers by at least 2 increments at each subsequent time point.
This demonstrates that isolate NU-2 is producing consider-
ably more capsule than isolate 184A and is releasing it into
the medium at a greater rate than isolate 184A.
Discussion
These data give growth rate estimates for two isolates of
C. neoformans. The 184A isolate exhibits a much faster
growth rate than the NU-2 isolate. This is an important dif-
erence in the two isolates. Ithas been postulated that isolate
MU-2 is more virulent in mice than isolate 184A because it
grows faster and simply overwhelms the host with cell num-
bers. The data present suggests otherwise. The growth rates
also give the approximate doubling time of both isolates.
Isolate 184A cell numbers doubled approximately every 4
hours, whereas isolate NU-2 cell numbers doubled approx-
imately every 12 hours. These data suggest an optimal time
of retrieving mRNA from the cells which would be after 4
hours for isolate 184A and after 8-12 hours for isolate NU-2.
The doubling time is important for mRNA retrieval because
the cells must be adequately growing and producing RNA.
This doubling time willbe considered with the time frame
of the capsular production to find the optimal time for
mRNA isolation.
The kinetics of the yeast cell size without the polysac-
charide capsule is also an important difference between the
two isolates because it too may contribute to the virulence of
isolate NU-2 The greater cell size may cause the organism
to occlude airways into the lung. The data from this
experiment indicated that the yeast cell diameter without
the polysaccharide capsule of yeast cells from isolate 184A
stayed approximately the same throughout the 48 hour peri-
od. In contrast, the yeast cell diameter of isolate NU-2
increased over the first 24 hours and then leveled off. The
question surrounding this proven growth in size of NU-2
cells is whether the cell is actually producing more protein
material or just swelling with water intake. This is significant
because if isolate NU-2 is producing more protein material,
this material may contribute to its virulence. This mecha-
nism is also significant because itcould allow treatment for
reducing the size ofNU-2 to reduce pulmonary and dessim-
inated systemic infections. Further studies on the biomass
willhave to be completed to understand the mechanism by
which cell size increases.
We also explored the production of the polysaccharide
capsule. This is an important differing characteristic of the
two C. neoformans isolates because the capsule is a factor in
the virulence of isolate NU-2. A larger capsule may more
effectively protect the yeast from host effecter cells such as
alveolar macrophages in the lung (Bulmer and Sans, 1968;
Swenson and Kozel, 1978). This experiment examined the
kinetics of the capsular production. There was little capsule
production by isolate 184A while isolate NU-2 produced
excessive amounts of capsule, especially within the first
eight hours. Using this information, the optimal time to
extract capsule gene mRNA from isolate NU-2 without the
interference of excessive capsular material would be in the
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first eight hours. More kinetic studies with smaller time
intervals would be needed to find the specific optimal time
point in this eight hour span.
Alatex agglutination test was also performed to observe
the kinetics of capsular material that was shed into the cul-
ture medium. Itis well documented that increasing crypto-
coccal antigen titers are characteristic of a poor prognosis
while decreasing antigen titers signify a good prognosis
(Diamond and Bennett, 1974). Excess capsular polysaccha-
ride likely affects host reactivity. The experiment results
show that isolate NU-2 was producing and shedding capsu-
lar material throughout the entire experiment. The titers
were constantly increasing which confirms the results from
the measurement of the actual polysaccharide capsule.
These data help to explain why isolate NU-2 is more often
fatal than 184A in experimental animals. Isolate 184A did
not begin producing capsular material for 12 hours but the
titers increased thereafter. This fact seems to indicate that an
optimal time for RNA retrieval from isolate 184A would be
after 12 hours, and the RNA from isolate NU-2 should be
retrieved as soon as possible. More precise experiments
with smaller time intervals willhave to be done to get the
precise time when the isolates are both actively growing and
reproducing and not producing excessive capsular material.
These data narrow down the optimal time for retrieval, but
it is stillquite broad.
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